AUSTIN, Texas and TOKYO, Sept. 9, 2025 /PRNewswire/ -- "The Lateral Flow Assays Market Size was US$ 7.51 billion in 2024, with a rise of US$ 7.50 billion in 2024, and is expected to reach US$ 15.68 ...
Dublin, March 24, 2025 (GLOBE NEWSWIRE) -- The "Lateral Flow Assays Market - Focused Insights 2025-2030" report has been added to ResearchAndMarkets.com's offering. The Lateral Flow Assays Market was ...
SHERIDAN, Wyo., Sept. 22, 2026 /PRNewswire/ -- The global lateral flow assay market is projected to grow from USD 11.04 billion in 2026 to USD 16.37 billion by 2031, registering a CAGR of 8.2% during ...
Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.
A new evaluation in Parasites & Vectors shows the trūRapid™ FOUR heartworm antigen test detects Dirofilaria immitis infection ...
Intelligent Bio Solutions expects a sixth U.S. patent for its innovative non-invasive drug testing technology, enhancing market entry plans. Intelligent Bio Solutions Inc. (INBS), a medical technology ...
Lateral flow immunoassays (LFIAs) represent a class of paper-based diagnostic devices designed for rapid, on-site detection of specific biomarkers in complex samples. At their core, these assays rely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results